AI ASSISTANT
Ask DrugCentral
Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
Try a sample question
Select a question to fill the search bar, then submit it or edit it first.
AI can make mistakes. Verify answers against the original sources before relying on them.
nicotinic acid 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| nicotinic acid or nicotinoyl alcohol derivatives | 2835 | 59-67-6 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 0.20 | g | O |
| 0.20 | g | P |
| 2 | g | O |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 1 | Benet LZ, Broccatelli F, Oprea TI |
| S (Water solubility) | 18 mg/mL | Bocci G, Oprea TI, Benet LZ |
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 101.53 µM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
| BA (Bioavailability) | 68 % |
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | -3.146 | High | 1 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 0.635 | High | 1 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 2.529 | 10^-6 cm/s | High | 1 |
| dh-clint | Dog hepatocyte intrinsic clearance | 1.637 | uL/min/10^6 cells | High | 1 |
| dppb | Dog plasma protein binding (% unbound) | 71.010 | % | High | 1 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 76.760 | % | High | 1 |
| herg | hERG pIC50 | 4.588 | pIC50 | High | 1 |
| hh-clint | Human hepatocyte intrinsic clearance | 2.642 | uL/min/10^6 cells | High | 1 |
| hlm-clint | Human liver microsomal intrinsic clearance | 3.319 | uL/min/mg protein | High | 1 |
| hppb | Human plasma protein binding (% unbound) | 78.090 | % | High | 1 |
| kinase-safety-class | ACVR2A,ACVR2B,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GRK3,GSK3B,ITK,JAK1,JAK2,KDR,MAP2K6,MAP3K14,MAP3K21,MAP3K7,MAPK12,MAPK7,MAPK9,MAPKAPK2,MTOR,NTRK2,PDK1,PDK2,PIK3CB,PIK3CD,PIM2,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ULK1 | 51 | |||
| kinase-selectivity-class | ACVR2B,AXL,BRAF,CDK9,DYRK1B,EIF2AK3,EPHB4,GRK2,MAPK7,PIK3CD,PRKDC,SIK2,STK33,TGFBR1,TTK | 15 | |||
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 0.389 | High | 1 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 1.321 | High | 1 | |
| mppb | Mouse plasma protein binding (% unbound) | 93.860 | High | 1 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 0.318 | High | 1 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pld-class | Phospholipidosis risk class (1 = positive, 0 = negative) | 0 | High | 1 | |
| pppb | Pig plasma protein binding (% unbound) | 71.990 | % | High | 1 |
| rh-clint | Rat hepatocyte intrinsic clearance | 1.189 | uL/min/10^6 cells | High | 1 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 91.450 | % | High | 1 |
| rppb | Rat plasma protein binding (% unbound) | 63.950 | % | High | 1 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 950.605 | uM | High | 1 |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| July 24, 1957 | FDA | MEDPOINTE PHARM HLC |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Pemphigus | 164.73 | 9.84 | 6 | 52999 | 326858 | 90248584 |
| Synovitis | 159.72 | 9.84 | 8 | 52997 | 329744 | 90245698 |
| Hand deformity | 154.53 | 9.84 | 4 | 53001 | 296358 | 90279084 |
| Contraindicated product administered | 142.56 | 9.84 | 12 | 52993 | 320127 | 90255315 |
| Systemic lupus erythematosus | 137.95 | 9.84 | 23 | 52982 | 361873 | 90213569 |
| Glossodynia | 133.04 | 9.84 | 16 | 52989 | 321763 | 90253679 |
| Infusion related reaction | 128.29 | 9.84 | 42 | 52963 | 416738 | 90158704 |
| Anti-cyclic citrullinated peptide antibody positive | 120.28 | 9.84 | 4 | 53001 | 236429 | 90339013 |
| Product dose omission issue | 119.77 | 9.84 | 409 | 52596 | 291278 | 90284164 |
| Pericarditis | 117.89 | 9.84 | 11 | 52994 | 270140 | 90305302 |
| Off label use | 114.01 | 9.84 | 303 | 52702 | 1101949 | 89473493 |
| Product use in unapproved indication | 108.64 | 9.84 | 31 | 52974 | 336205 | 90239237 |
| Wound | 107.47 | 9.84 | 23 | 52982 | 302957 | 90272485 |
| Duodenal ulcer perforation | 102.14 | 9.84 | 7 | 52998 | 221281 | 90354161 |
| Fall | 99.62 | 9.84 | 549 | 52456 | 481261 | 90094181 |
| Helicobacter infection | 99.60 | 9.84 | 9 | 52996 | 226841 | 90348601 |
| Treatment failure | 98.22 | 9.84 | 28 | 52977 | 303900 | 90271542 |
| Maternal exposure during pregnancy | 96.40 | 9.84 | 45 | 52960 | 360018 | 90215424 |
| Diarrhoea | 89.42 | 9.84 | 889 | 52116 | 938301 | 89637141 |
| Drug intolerance | 84.90 | 9.84 | 82 | 52923 | 447509 | 90127933 |
| Folliculitis | 84.82 | 9.84 | 10 | 52995 | 204343 | 90371099 |
| Rheumatoid factor positive | 83.59 | 9.84 | 4 | 53001 | 171646 | 90403796 |
| Lower respiratory tract infection | 77.52 | 9.84 | 25 | 52980 | 250634 | 90324808 |
| Muscle injury | 74.94 | 9.84 | 8 | 52997 | 176646 | 90398796 |
| General physical health deterioration | 73.40 | 9.84 | 60 | 52945 | 355055 | 90220387 |
| Rheumatic fever | 73.19 | 9.84 | 4 | 53001 | 153117 | 90422325 |
| Unevaluable event | 71.79 | 9.84 | 121 | 52884 | 54727 | 90520715 |
| Product use issue | 71.66 | 9.84 | 53 | 52952 | 329866 | 90245576 |
| Therapy cessation | 65.54 | 9.84 | 93 | 52912 | 36268 | 90539174 |
| Feeling abnormal | 65.50 | 9.84 | 231 | 52774 | 167004 | 90408438 |
| Type 2 diabetes mellitus | 65.13 | 9.84 | 19 | 52986 | 203225 | 90372217 |
| Liver injury | 62.42 | 9.84 | 12 | 52993 | 170555 | 90404887 |
| Fatigue | 61.68 | 9.84 | 981 | 52024 | 1153042 | 89422400 |
| Device expulsion | 61.40 | 9.84 | 96 | 52909 | 40790 | 90534652 |
| C-reactive protein abnormal | 58.88 | 9.84 | 4 | 53001 | 127425 | 90448017 |
| Hepatic enzyme increased | 58.58 | 9.84 | 75 | 52930 | 360661 | 90214781 |
| Irritable bowel syndrome | 58.53 | 9.84 | 24 | 52981 | 207424 | 90368018 |
| Muscle spasms | 58.07 | 9.84 | 296 | 52709 | 251587 | 90323855 |
| Arthropathy | 57.58 | 9.84 | 78 | 52927 | 366164 | 90209278 |
| Sleep disorder due to general medical condition, insomnia type | 56.76 | 9.84 | 5 | 53000 | 128689 | 90446753 |
| C-reactive protein increased | 56.23 | 9.84 | 18 | 52987 | 181371 | 90394071 |
| Deep vein thrombosis | 53.01 | 9.84 | 145 | 52860 | 91475 | 90483967 |
| Back pain | 52.95 | 9.84 | 342 | 52663 | 316833 | 90258609 |
| Full blood count decreased | 52.13 | 9.84 | 75 | 52930 | 29614 | 90545828 |
| Neuropathy peripheral | 50.90 | 9.84 | 186 | 52819 | 136784 | 90438658 |
| Impaired healing | 50.34 | 9.84 | 38 | 52967 | 234161 | 90341281 |
| Intentional product use issue | 49.50 | 9.84 | 33 | 52972 | 216859 | 90358583 |
| Dizziness | 48.86 | 9.84 | 543 | 52462 | 588741 | 89986701 |
| Drug ineffective | 48.40 | 9.84 | 548 | 52457 | 1383750 | 89191692 |
| Ill-defined disorder | 48.07 | 9.84 | 24 | 52981 | 184867 | 90390575 |
| Therapeutic product effect decreased | 47.92 | 9.84 | 55 | 52950 | 277516 | 90297926 |
| Therapeutic product effect incomplete | 47.73 | 9.84 | 27 | 52978 | 193869 | 90381573 |
| Nausea | 47.43 | 9.84 | 911 | 52094 | 1109405 | 89466037 |
| Discomfort | 46.67 | 9.84 | 55 | 52950 | 274280 | 90301162 |
| Constipation | 45.97 | 9.84 | 301 | 52704 | 280094 | 90295348 |
| Joint swelling | 45.49 | 9.84 | 147 | 52858 | 503153 | 90072289 |
| Myalgia | 45.49 | 9.84 | 213 | 52792 | 174912 | 90400530 |
| Fibromyalgia | 44.93 | 9.84 | 33 | 52972 | 206236 | 90369206 |
| Swollen joint count increased | 44.77 | 9.84 | 6 | 52999 | 111200 | 90464242 |
| Blister | 44.59 | 9.84 | 50 | 52955 | 254948 | 90320494 |
| Flushing | 43.41 | 9.84 | 132 | 52873 | 88359 | 90487083 |
| Device dislocation | 43.26 | 9.84 | 71 | 52934 | 31411 | 90544031 |
| Toxicity to various agents | 41.59 | 9.84 | 65 | 52940 | 287781 | 90287661 |
| Discoloured vomit | 41.22 | 9.84 | 18 | 52987 | 1174 | 90574268 |
| Cardiac failure congestive | 40.94 | 9.84 | 139 | 52866 | 98555 | 90476887 |
| Facet joint syndrome | 40.35 | 9.84 | 5 | 53000 | 98384 | 90477058 |
| Wheezing | 38.11 | 9.84 | 50 | 52955 | 238030 | 90337412 |
| Dehydration | 37.68 | 9.84 | 218 | 52787 | 194229 | 90381213 |
| Alopecia | 37.24 | 9.84 | 156 | 52849 | 494915 | 90080527 |
| Hypercholesterolaemia | 37.11 | 9.84 | 7 | 52998 | 100885 | 90474557 |
| Plasma cell myeloma | 37.06 | 9.84 | 77 | 52928 | 40751 | 90534691 |
| Drug abuse | 36.85 | 9.84 | 3 | 53002 | 82344 | 90493098 |
| Urticaria thermal | 35.81 | 9.84 | 13 | 52992 | 520 | 90574922 |
| Tremor | 35.26 | 9.84 | 180 | 52825 | 152993 | 90422449 |
| Lip dry | 35.08 | 9.84 | 8 | 52997 | 100947 | 90474495 |
| Injection site pain | 33.82 | 9.84 | 195 | 52810 | 173504 | 90401938 |
| Haemoglobin decreased | 33.64 | 9.84 | 185 | 52820 | 161771 | 90413671 |
| Injection site bruising | 33.51 | 9.84 | 86 | 52919 | 52221 | 90523221 |
| Headache | 33.43 | 9.84 | 698 | 52307 | 862048 | 89713394 |
| Hot flush | 33.26 | 9.84 | 93 | 52912 | 59395 | 90516047 |
| Urinary tract infection | 33.19 | 9.84 | 298 | 52707 | 305334 | 90270108 |
| Rheumatoid arthritis | 31.98 | 9.84 | 107 | 52898 | 362507 | 90212935 |
| Flatulence | 31.84 | 9.84 | 73 | 52932 | 41294 | 90534148 |
| Nervousness | 31.82 | 9.84 | 65 | 52940 | 33991 | 90541451 |
| Obesity | 31.76 | 9.84 | 11 | 52994 | 105496 | 90469946 |
| Prescribed overdose | 31.49 | 9.84 | 9 | 52996 | 97616 | 90477826 |
| Joint range of motion decreased | 30.45 | 9.84 | 21 | 52984 | 135622 | 90439820 |
| Asthenia | 29.55 | 9.84 | 457 | 52548 | 533294 | 90042148 |
| Administration site erythema | 29.09 | 9.84 | 13 | 52992 | 896 | 90574546 |
| Injection site erythema | 28.71 | 9.84 | 124 | 52881 | 98378 | 90477064 |
| Nasal congestion | 28.26 | 9.84 | 110 | 52895 | 83304 | 90492138 |
| Psoriasis | 28.19 | 9.84 | 165 | 52840 | 147589 | 90427853 |
| Exposure during pregnancy | 28.06 | 9.84 | 61 | 52944 | 238349 | 90337093 |
| Epilepsy | 27.61 | 9.84 | 7 | 52998 | 82199 | 90493243 |
| Injection site haemorrhage | 27.59 | 9.84 | 55 | 52950 | 28263 | 90547179 |
| Pulmonary embolism | 27.54 | 9.84 | 150 | 52855 | 130670 | 90444772 |
| Grip strength decreased | 27.27 | 9.84 | 10 | 52995 | 92566 | 90482876 |
| Femoral artery dissection | 26.87 | 9.84 | 6 | 52999 | 37 | 90575405 |
| Condition aggravated | 26.47 | 9.84 | 222 | 52783 | 595323 | 89980119 |
| Pulmonary fibrosis | 26.40 | 9.84 | 15 | 52990 | 107488 | 90467954 |
| Wound infection | 25.91 | 9.84 | 15 | 52990 | 106387 | 90469055 |
| Pelvic pain | 25.80 | 9.84 | 38 | 52967 | 15319 | 90560123 |
| Stomatitis | 25.65 | 9.84 | 79 | 52926 | 274619 | 90300823 |
| Abdominal discomfort | 25.46 | 9.84 | 169 | 52836 | 477159 | 90098283 |
| Influenza like illness | 25.46 | 9.84 | 104 | 52901 | 80507 | 90494935 |
| Body height decreased | 25.22 | 9.84 | 33 | 52972 | 11916 | 90563526 |
| Hip fracture | 25.04 | 9.84 | 58 | 52947 | 33019 | 90542423 |
| Internal haemorrhage | 24.92 | 9.84 | 24 | 52981 | 6196 | 90569246 |
| Swelling | 24.61 | 9.84 | 144 | 52861 | 418914 | 90156528 |
| COVID-19 | 24.49 | 9.84 | 38 | 52967 | 168805 | 90406637 |
| Mobility decreased | 24.20 | 9.84 | 71 | 52934 | 250663 | 90324779 |
| Atrial fibrillation | 24.08 | 9.84 | 147 | 52858 | 133464 | 90441978 |
| Gastrointestinal disorder | 23.83 | 9.84 | 74 | 52931 | 256613 | 90318829 |
| Chills | 23.65 | 9.84 | 145 | 52860 | 131836 | 90443606 |
| Skin discolouration | 23.53 | 9.84 | 68 | 52937 | 44247 | 90531195 |
| Lung disorder | 23.44 | 9.84 | 32 | 52973 | 149851 | 90425591 |
| Pneumonia | 23.29 | 9.84 | 512 | 52493 | 637547 | 89937895 |
| Sleep disorder | 23.03 | 9.84 | 51 | 52954 | 197979 | 90377463 |
| Thrombosis | 21.95 | 9.84 | 93 | 52912 | 73158 | 90502284 |
| Peripheral venous disease | 21.64 | 9.84 | 11 | 52994 | 83910 | 90491532 |
| Hypervolaemia | 21.13 | 9.84 | 54 | 52951 | 32703 | 90542739 |
| Red blood cell sedimentation rate increased | 21.04 | 9.84 | 11 | 52994 | 82584 | 90492858 |
| Cyst | 20.96 | 9.84 | 36 | 52969 | 16525 | 90558917 |
| Dyspnoea | 20.91 | 9.84 | 668 | 52337 | 880287 | 89695155 |
| Tooth disorder | 20.83 | 9.84 | 52 | 52953 | 31038 | 90544404 |
| Dizziness postural | 20.68 | 9.84 | 26 | 52979 | 9027 | 90566415 |
| Eye swelling | 20.59 | 9.84 | 50 | 52955 | 29336 | 90546106 |
| Blood potassium decreased | 20.48 | 9.84 | 68 | 52937 | 47659 | 90527783 |
| Hypersensitivity | 20.40 | 9.84 | 169 | 52836 | 454508 | 90120934 |
| Dislocation of vertebra | 20.33 | 9.84 | 4 | 53001 | 55964 | 90519478 |
| White blood cell count decreased | 20.25 | 9.84 | 167 | 52838 | 166942 | 90408500 |
| Balance disorder | 20.22 | 9.84 | 111 | 52894 | 96969 | 90478473 |
| Drug hypersensitivity | 20.20 | 9.84 | 382 | 52623 | 463227 | 90112215 |
| Laboratory test abnormal | 20.11 | 9.84 | 62 | 52943 | 41792 | 90533650 |
| Blood cholesterol increased | 20.00 | 9.84 | 59 | 52946 | 207953 | 90367489 |
| Autoimmune disorder | 19.88 | 9.84 | 10 | 52995 | 76734 | 90498708 |
| Bursitis | 19.70 | 9.84 | 29 | 52976 | 131625 | 90443817 |
| Live birth | 19.48 | 9.84 | 11 | 52994 | 79096 | 90496346 |
| Multiple sclerosis relapse | 19.39 | 9.84 | 71 | 52934 | 52234 | 90523208 |
| Dysgeusia | 19.19 | 9.84 | 71 | 52934 | 52489 | 90522953 |
| Rhinorrhoea | 19.08 | 9.84 | 102 | 52903 | 88214 | 90487228 |
| International normalised ratio increased | 19.05 | 9.84 | 66 | 52939 | 47250 | 90528192 |
| Sinoatrial block | 18.93 | 9.84 | 10 | 52995 | 995 | 90574447 |
| Dyspnoea exertional | 18.81 | 9.84 | 88 | 52917 | 72200 | 90503242 |
| Vaginal haemorrhage | 18.58 | 9.84 | 50 | 52955 | 31221 | 90544221 |
| Bone pain | 18.03 | 9.84 | 78 | 52927 | 61905 | 90513537 |
| Vision blurred | 17.80 | 9.84 | 118 | 52887 | 110175 | 90465267 |
| Cardiac disorder | 16.88 | 9.84 | 72 | 52933 | 56800 | 90518642 |
| Product complaint | 16.63 | 9.84 | 29 | 52976 | 13471 | 90561971 |
| Dry skin | 16.56 | 9.84 | 98 | 52907 | 87975 | 90487467 |
| Pain in extremity | 16.56 | 9.84 | 362 | 52643 | 450167 | 90125275 |
| Lethargy | 16.53 | 9.84 | 77 | 52928 | 63062 | 90512380 |
| Infection | 16.50 | 9.84 | 134 | 52871 | 361960 | 90213482 |
| Influenza | 15.72 | 9.84 | 137 | 52868 | 139127 | 90436315 |
| Overdose | 15.69 | 9.84 | 44 | 52961 | 157665 | 90417777 |
| Burning sensation | 15.60 | 9.84 | 76 | 52929 | 63376 | 90512066 |
| Bronchitis | 15.51 | 9.84 | 147 | 52858 | 152780 | 90422662 |
| Hypertension | 15.51 | 9.84 | 182 | 52823 | 457350 | 90118092 |
| Drug-induced liver injury | 15.46 | 9.84 | 18 | 52987 | 90300 | 90485142 |
| Asthma | 15.40 | 9.84 | 81 | 52924 | 242079 | 90333363 |
| Fluid retention | 15.29 | 9.84 | 96 | 52909 | 87995 | 90487447 |
| Pigmentation disorder | 15.07 | 9.84 | 18 | 52987 | 5931 | 90569511 |
| Hypoacusis | 15.04 | 9.84 | 43 | 52962 | 27807 | 90547635 |
| Injection site mass | 14.86 | 9.84 | 37 | 52968 | 22053 | 90553389 |
| Intentional overdose | 14.70 | 9.84 | 20 | 52985 | 93814 | 90481628 |
| Pulmonary arterial hypertension | 14.69 | 9.84 | 41 | 52964 | 26146 | 90549296 |
| Coeliac disease | 14.59 | 9.84 | 4 | 53001 | 44606 | 90530836 |
| Depression | 14.59 | 9.84 | 252 | 52753 | 300349 | 90275093 |
| Injection site reaction | 14.54 | 9.84 | 98 | 52907 | 91982 | 90483460 |
| Hypophagia | 14.36 | 9.84 | 50 | 52955 | 35887 | 90539555 |
| Pulmonary hypertension | 14.33 | 9.84 | 56 | 52949 | 42467 | 90532975 |
| Ageusia | 14.21 | 9.84 | 30 | 52975 | 16046 | 90559396 |
| Gallbladder disorder | 14.20 | 9.84 | 34 | 52971 | 19769 | 90555673 |
| Platelet count decreased | 14.06 | 9.84 | 132 | 52873 | 136837 | 90438605 |
| Cough | 14.04 | 9.84 | 298 | 52707 | 368664 | 90206778 |
| Nocturia | 13.92 | 9.84 | 23 | 52982 | 10232 | 90565210 |
| Oedema peripheral | 13.91 | 9.84 | 220 | 52785 | 257695 | 90317747 |
| Hypoxia | 13.90 | 9.84 | 81 | 52924 | 72318 | 90503124 |
| Adverse event | 13.84 | 9.84 | 30 | 52975 | 117388 | 90458054 |
| Adjustment disorder with depressed mood | 13.82 | 9.84 | 8 | 52997 | 56745 | 90518697 |
| Cellulitis | 13.71 | 9.84 | 96 | 52909 | 91241 | 90484201 |
| Small intestinal obstruction | 13.69 | 9.84 | 35 | 52970 | 21199 | 90554243 |
| Hepatic function abnormal | 13.63 | 9.84 | 5 | 53000 | 46283 | 90529159 |
| Inflammation | 13.57 | 9.84 | 56 | 52949 | 178536 | 90396906 |
| Blood glucose decreased | 13.46 | 9.84 | 37 | 52968 | 23392 | 90552050 |
| Nail disorder | 13.45 | 9.84 | 9 | 52996 | 59058 | 90516384 |
| Blepharospasm | 13.24 | 9.84 | 8 | 52997 | 55437 | 90520005 |
| X-ray abnormal | 13.22 | 9.84 | 5 | 53000 | 45419 | 90530023 |
| Multiple sclerosis | 13.15 | 9.84 | 41 | 52964 | 27799 | 90547643 |
| Multiple allergies | 13.09 | 9.84 | 28 | 52977 | 15118 | 90560324 |
| Aspartate aminotransferase increased | 13.07 | 9.84 | 104 | 52901 | 102833 | 90472609 |
| Pleural effusion | 13.07 | 9.84 | 111 | 52894 | 111880 | 90463562 |
| Anxiety | 13.05 | 9.84 | 254 | 52751 | 309518 | 90265924 |
| Pain in jaw | 12.91 | 9.84 | 59 | 52946 | 47926 | 90527516 |
| Sleep disorder due to a general medical condition | 12.90 | 9.84 | 5 | 53000 | 44733 | 90530709 |
| Administration site swelling | 12.84 | 9.84 | 9 | 52996 | 1490 | 90573952 |
| Plasma cell myeloma recurrent | 12.75 | 9.84 | 14 | 52991 | 4214 | 90571228 |
| Cerebrovascular accident | 12.65 | 9.84 | 119 | 52886 | 123414 | 90452028 |
| Dry eye | 12.57 | 9.84 | 67 | 52938 | 57864 | 90517578 |
| Gait disturbance | 12.50 | 9.84 | 218 | 52787 | 260278 | 90315164 |
| Musculoskeletal stiffness | 12.49 | 9.84 | 112 | 52893 | 296420 | 90279022 |
| Restless legs syndrome | 12.43 | 9.84 | 35 | 52970 | 22435 | 90553007 |
| Chest pain | 12.43 | 9.84 | 259 | 52746 | 319386 | 90256056 |
| Pollakiuria | 12.40 | 9.84 | 45 | 52960 | 32960 | 90542482 |
| Upper limb fracture | 12.32 | 9.84 | 34 | 52971 | 21544 | 90553898 |
| Confusional state | 12.18 | 9.84 | 156 | 52849 | 386049 | 90189393 |
| Hospice care | 12.15 | 9.84 | 21 | 52984 | 9683 | 90565759 |
| Rotator cuff syndrome | 12.14 | 9.84 | 28 | 52977 | 15891 | 90559551 |
| Eustachian tube obstruction | 11.82 | 9.84 | 3 | 53002 | 34 | 90575408 |
| Lupus-like syndrome | 11.73 | 9.84 | 7 | 52998 | 48839 | 90526603 |
| Agranulocytosis | 11.71 | 9.84 | 3 | 53002 | 34999 | 90540443 |
| Haematocrit decreased | 11.68 | 9.84 | 52 | 52953 | 41780 | 90533662 |
| Chest discomfort | 11.64 | 9.84 | 128 | 52877 | 138237 | 90437205 |
| International normalised ratio decreased | 11.48 | 9.84 | 14 | 52991 | 4710 | 90570732 |
| Blood triglycerides increased | 11.39 | 9.84 | 25 | 52980 | 13736 | 90561706 |
| Intestinal dilatation | 11.37 | 9.84 | 10 | 52995 | 2300 | 90573142 |
| Very low density lipoprotein increased | 11.34 | 9.84 | 4 | 53001 | 147 | 90575295 |
| Endometriosis | 11.28 | 9.84 | 16 | 52989 | 6232 | 90569210 |
| Febrile neutropenia | 11.20 | 9.84 | 51 | 52954 | 158298 | 90417144 |
| Blood potassium increased | 11.17 | 9.84 | 32 | 52973 | 20717 | 90554725 |
| Coronary artery disease | 11.11 | 9.84 | 44 | 52961 | 33579 | 90541863 |
| Therapeutic response unexpected | 11.06 | 9.84 | 33 | 52972 | 21847 | 90553595 |
| Insomnia | 11.01 | 9.84 | 264 | 52741 | 333210 | 90242232 |
| Cold sweat | 11.00 | 9.84 | 25 | 52980 | 14056 | 90561386 |
| Scratch | 10.63 | 9.84 | 20 | 52985 | 9846 | 90565596 |
| Psoriatic arthropathy | 10.62 | 9.84 | 84 | 52921 | 228251 | 90347191 |
| Cardiac pacemaker insertion | 10.61 | 9.84 | 13 | 52992 | 4394 | 90571048 |
| Laryngeal pain | 10.58 | 9.84 | 13 | 52992 | 4409 | 90571033 |
| Meniscus injury | 10.55 | 9.84 | 18 | 52987 | 8219 | 90567223 |
| Haematoma | 10.50 | 9.84 | 48 | 52957 | 39000 | 90536442 |
| Complication associated with device | 10.47 | 9.84 | 30 | 52975 | 19419 | 90556023 |
| Cholecystectomy | 10.47 | 9.84 | 22 | 52983 | 11733 | 90563709 |
| Heavy menstrual bleeding | 10.41 | 9.84 | 31 | 52974 | 20499 | 90554943 |
| Blood glucose increased | 10.38 | 9.84 | 93 | 52912 | 95153 | 90480289 |
| Anaemia | 10.38 | 9.84 | 275 | 52730 | 352527 | 90222915 |
| Pulmonary oedema | 10.37 | 9.84 | 67 | 52938 | 62013 | 90513429 |
| Interstitial lung disease | 10.33 | 9.84 | 18 | 52987 | 76387 | 90499055 |
| Adverse drug reaction | 10.29 | 9.84 | 109 | 52896 | 116592 | 90458850 |
| Pulse absent | 10.20 | 9.84 | 15 | 52990 | 6040 | 90569402 |
| Chronic kidney disease | 10.19 | 9.84 | 57 | 52948 | 50134 | 90525308 |
| Breast cancer stage II | 10.10 | 9.84 | 4 | 53001 | 35330 | 90540112 |
| Osteopenia | 10.07 | 9.84 | 33 | 52972 | 22969 | 90552473 |
| Night sweats | 10.01 | 9.84 | 40 | 52965 | 128726 | 90446716 |
| Stress fracture | 9.97 | 9.84 | 18 | 52987 | 8593 | 90566849 |
| Injury | 9.94 | 9.84 | 71 | 52934 | 197278 | 90378164 |
| Rib fracture | 9.89 | 9.84 | 36 | 52969 | 26399 | 90549043 |
| Rash pruritic | 9.86 | 9.84 | 82 | 52923 | 82132 | 90493310 |
| Liver disorder | 9.86 | 9.84 | 37 | 52968 | 121232 | 90454210 |
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Off label use | 171.34 | 11.57 | 175 | 36042 | 638160 | 41946958 |
| Product use in unapproved indication | 100.05 | 11.57 | 18 | 36199 | 184438 | 42400680 |
| Drug abuse | 72.72 | 11.57 | 4 | 36213 | 104767 | 42480351 |
| Flushing | 69.54 | 11.57 | 118 | 36099 | 36910 | 42548208 |
| Fatigue | 61.17 | 11.57 | 601 | 35616 | 435040 | 42150078 |
| Asthenia | 53.17 | 11.57 | 414 | 35803 | 280379 | 42304739 |
| Plasma cell myeloma | 51.07 | 11.57 | 120 | 36097 | 47458 | 42537660 |
| Diarrhoea | 50.85 | 11.57 | 606 | 35611 | 460243 | 42124875 |
| Toxicity to various agents | 47.40 | 11.57 | 76 | 36141 | 229060 | 42356058 |
| Product dose omission issue | 45.90 | 11.57 | 255 | 35962 | 154110 | 42431008 |
| General physical health deterioration | 44.33 | 11.57 | 38 | 36179 | 151208 | 42433910 |
| Dizziness | 42.54 | 11.57 | 359 | 35858 | 248895 | 42336223 |
| Completed suicide | 39.89 | 11.57 | 16 | 36201 | 96449 | 42488669 |
| Myalgia | 39.43 | 11.57 | 174 | 36043 | 95906 | 42489212 |
| Laboratory test abnormal | 38.94 | 11.57 | 70 | 36147 | 22908 | 42562210 |
| Full blood count decreased | 35.30 | 11.57 | 63 | 36154 | 20497 | 42564621 |
| Fall | 34.95 | 11.57 | 328 | 35889 | 234192 | 42350926 |
| Muscle spasms | 33.18 | 11.57 | 153 | 36064 | 85891 | 42499227 |
| Febrile neutropenia | 31.83 | 11.57 | 69 | 36148 | 185634 | 42399484 |
| Drug interaction | 31.25 | 11.57 | 119 | 36098 | 266880 | 42318238 |
| Drug hypersensitivity | 30.05 | 11.57 | 165 | 36052 | 99224 | 42485894 |
| Intentional product use issue | 27.97 | 11.57 | 13 | 36204 | 71820 | 42513298 |
| Cytokine release syndrome | 27.25 | 11.57 | 3 | 36214 | 44524 | 42540594 |
| COVID-19 | 26.34 | 11.57 | 36 | 36181 | 115912 | 42469206 |
| Intentional overdose | 25.83 | 11.57 | 6 | 36211 | 51450 | 42533668 |
| Blood testosterone decreased | 25.79 | 11.57 | 26 | 36191 | 4876 | 42580242 |
| White blood cell count decreased | 25.56 | 11.57 | 171 | 36046 | 110225 | 42474893 |
| Psoriasis | 25.48 | 11.57 | 95 | 36122 | 48509 | 42536609 |
| Treatment failure | 24.90 | 11.57 | 11 | 36206 | 62613 | 42522505 |
| Adverse drug reaction | 23.80 | 11.57 | 78 | 36139 | 37356 | 42547762 |
| Gastrointestinal haemorrhage | 23.61 | 11.57 | 153 | 36064 | 97573 | 42487545 |
| Myocardial infarction | 23.47 | 11.57 | 183 | 36034 | 123826 | 42461292 |
| Drug ineffective | 23.45 | 11.57 | 386 | 35831 | 629811 | 41955307 |
| Hypoaesthesia | 23.20 | 11.57 | 121 | 36096 | 71342 | 42513776 |
| Sinusitis | 22.79 | 11.57 | 90 | 36127 | 47202 | 42537916 |
| Interstitial lung disease | 22.62 | 11.57 | 20 | 36197 | 78442 | 42506676 |
| Cardiac disorder | 21.89 | 11.57 | 91 | 36126 | 48841 | 42536277 |
| Product use issue | 21.61 | 11.57 | 20 | 36197 | 76731 | 42508387 |
| Mental status changes | 20.98 | 11.57 | 81 | 36136 | 42034 | 42543084 |
| Meningitis cryptococcal | 20.25 | 11.57 | 19 | 36198 | 3264 | 42581854 |
| Multiple organ dysfunction syndrome | 20.20 | 11.57 | 32 | 36185 | 97003 | 42488115 |
| Myelosuppression | 19.75 | 11.57 | 5 | 36212 | 40456 | 42544662 |
| Condition aggravated | 19.29 | 11.57 | 136 | 36081 | 260618 | 42324500 |
| Therapy cessation | 19.19 | 11.57 | 49 | 36168 | 20401 | 42564717 |
| Memory impairment | 19.12 | 11.57 | 89 | 36128 | 50133 | 42534985 |
| Hepatic function abnormal | 19.06 | 11.57 | 10 | 36207 | 51557 | 42533561 |
| Haemoglobin decreased | 19.05 | 11.57 | 184 | 36033 | 132287 | 42452831 |
| Coma | 18.90 | 11.57 | 11 | 36206 | 53543 | 42531575 |
| Drug ineffective for unapproved indication | 18.52 | 11.57 | 8 | 36209 | 46155 | 42538963 |
| Dehydration | 18.51 | 11.57 | 193 | 36024 | 141574 | 42443544 |
| Flatulence | 18.38 | 11.57 | 55 | 36162 | 25097 | 42560021 |
| Cerebrovascular accident | 17.62 | 11.57 | 142 | 36075 | 97018 | 42488100 |
| Drug resistance | 17.17 | 11.57 | 4 | 36213 | 34244 | 42550874 |
| Suicide attempt | 16.95 | 11.57 | 9 | 36208 | 46091 | 42539027 |
| Muscular weakness | 16.78 | 11.57 | 125 | 36092 | 83373 | 42501745 |
| Atelectasis | 16.74 | 11.57 | 45 | 36172 | 19316 | 42565802 |
| Coronary artery occlusion | 16.74 | 11.57 | 32 | 36185 | 10965 | 42574153 |
| Feeling abnormal | 16.69 | 11.57 | 109 | 36108 | 69677 | 42515441 |
| Cardiac failure congestive | 16.56 | 11.57 | 127 | 36090 | 85475 | 42499643 |
| Agranulocytosis | 16.54 | 11.57 | 3 | 36214 | 30609 | 42554509 |
| Viral infection | 16.27 | 11.57 | 49 | 36168 | 22434 | 42562684 |
| Leukopenia | 16.18 | 11.57 | 24 | 36193 | 74722 | 42510396 |
| Transaminases abnormal | 16.09 | 11.57 | 7 | 36210 | 309 | 42584809 |
| Rash | 16.02 | 11.57 | 327 | 35890 | 276627 | 42308491 |
| Fluid retention | 15.90 | 11.57 | 61 | 36156 | 31558 | 42553560 |
| Oedema peripheral | 15.80 | 11.57 | 181 | 36036 | 135895 | 42449223 |
| High density lipoprotein decreased | 15.79 | 11.57 | 18 | 36199 | 3879 | 42581239 |
| Weight decreased | 15.69 | 11.57 | 256 | 35961 | 207692 | 42377426 |
| Cardiac failure | 15.69 | 11.57 | 43 | 36174 | 106813 | 42478305 |
| Constipation | 15.46 | 11.57 | 208 | 36009 | 162083 | 42423035 |
| Influenza | 15.41 | 11.57 | 98 | 36119 | 62077 | 42523041 |
| Renal impairment | 14.99 | 11.57 | 46 | 36171 | 110182 | 42474936 |
| Cerebral small vessel ischaemic disease | 14.97 | 11.57 | 8 | 36209 | 558 | 42584560 |
| Nausea | 14.44 | 11.57 | 440 | 35777 | 396359 | 42188759 |
| Muscle fatigue | 14.42 | 11.57 | 12 | 36205 | 1759 | 42583359 |
| Neuropathy peripheral | 14.41 | 11.57 | 141 | 36076 | 101712 | 42483406 |
| Increased tendency to bruise | 14.13 | 11.57 | 18 | 36199 | 4352 | 42580766 |
| Dyspepsia | 14.10 | 11.57 | 71 | 36146 | 41281 | 42543837 |
| Unevaluable event | 13.97 | 11.57 | 62 | 36155 | 34226 | 42550892 |
| International normalised ratio increased | 13.90 | 11.57 | 79 | 36138 | 48089 | 42537029 |
| Altered state of consciousness | 13.56 | 11.57 | 4 | 36213 | 29255 | 42555863 |
| Influenza like illness | 13.30 | 11.57 | 58 | 36159 | 31782 | 42553336 |
| Headache | 13.30 | 11.57 | 281 | 35936 | 239088 | 42346030 |
| Back pain | 13.20 | 11.57 | 181 | 36036 | 141595 | 42443523 |
| Coronary artery disease | 12.90 | 11.57 | 84 | 36133 | 53636 | 42531482 |
| Cholestasis | 12.72 | 11.57 | 6 | 36211 | 32873 | 42552245 |
| Haematocrit decreased | 12.66 | 11.57 | 61 | 36156 | 34847 | 42550271 |
| Paraesthesia | 12.58 | 11.57 | 106 | 36111 | 73353 | 42511765 |
| Contraindicated product administered | 12.58 | 11.57 | 3 | 36214 | 25269 | 42559849 |
| Foetal exposure during pregnancy | 12.54 | 11.57 | 13 | 36204 | 47298 | 42537820 |
| C-reactive protein increased | 12.27 | 11.57 | 22 | 36195 | 63538 | 42521580 |
| Cellulitis | 12.26 | 11.57 | 92 | 36125 | 61493 | 42523625 |
| Obstructive airways disorder | 12.20 | 11.57 | 3 | 36214 | 24756 | 42560362 |
| Small intestinal obstruction | 12.17 | 11.57 | 37 | 36180 | 17024 | 42568094 |
| Gait disturbance | 12.11 | 11.57 | 132 | 36085 | 97868 | 42487250 |
| Bronchitis | 12.07 | 11.57 | 75 | 36142 | 47126 | 42537992 |
| Pneumonia | 12.03 | 11.57 | 455 | 35762 | 421694 | 42163424 |
| Application site exfoliation | 12.01 | 11.57 | 5 | 36212 | 198 | 42584920 |
| Blood glucose increased | 11.91 | 11.57 | 105 | 36112 | 73594 | 42511524 |
| Drug reaction with eosinophilia and systemic symptoms | 11.80 | 11.57 | 11 | 36206 | 42064 | 42543054 |
| Therapeutic product effect incomplete | 11.61 | 11.57 | 27 | 36190 | 70912 | 42514206 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Off label use | 228.24 | 9.78 | 374 | 69475 | 1499811 | 109019639 |
| Product use in unapproved indication | 166.76 | 9.78 | 39 | 69810 | 447338 | 110072112 |
| Synovitis | 143.86 | 9.78 | 7 | 69842 | 274085 | 110245365 |
| Product dose omission issue | 117.82 | 9.78 | 458 | 69391 | 321324 | 110198126 |
| Hand deformity | 116.55 | 9.78 | 5 | 69844 | 218501 | 110300949 |
| Contraindicated product administered | 111.59 | 9.78 | 13 | 69836 | 248254 | 110271196 |
| Pemphigus | 105.00 | 9.78 | 8 | 69841 | 214562 | 110304888 |
| Fall | 104.35 | 9.78 | 695 | 69154 | 602787 | 109916663 |
| Systemic lupus erythematosus | 103.39 | 9.78 | 18 | 69831 | 254320 | 110265130 |
| Treatment failure | 101.60 | 9.78 | 25 | 69824 | 277209 | 110242241 |
| Infusion related reaction | 100.43 | 9.78 | 58 | 69791 | 381104 | 110138346 |
| Completed suicide | 98.86 | 9.78 | 17 | 69832 | 242364 | 110277086 |
| Anti-cyclic citrullinated peptide antibody positive | 97.60 | 9.78 | 4 | 69845 | 181980 | 110337470 |
| Drug abuse | 94.81 | 9.78 | 4 | 69845 | 177407 | 110342043 |
| General physical health deterioration | 90.77 | 9.78 | 81 | 69768 | 425214 | 110094236 |
| Glossodynia | 89.60 | 9.78 | 16 | 69833 | 221988 | 110297462 |
| Drug intolerance | 81.38 | 9.78 | 82 | 69767 | 406430 | 110113020 |
| Dizziness | 81.06 | 9.78 | 733 | 69116 | 697460 | 109821990 |
| Duodenal ulcer perforation | 80.60 | 9.78 | 9 | 69840 | 177691 | 110341759 |
| Pericarditis | 79.81 | 9.78 | 20 | 69829 | 219094 | 110300356 |
| Helicobacter infection | 78.15 | 9.78 | 11 | 69838 | 181866 | 110337584 |
| Lower respiratory tract infection | 74.67 | 9.78 | 30 | 69819 | 243076 | 110276374 |
| Therapy cessation | 73.10 | 9.78 | 114 | 69735 | 44743 | 110474707 |
| Diarrhoea | 71.34 | 9.78 | 1061 | 68788 | 1138444 | 109381006 |
| Toxicity to various agents | 70.56 | 9.78 | 122 | 69727 | 480433 | 110039017 |
| C-reactive protein abnormal | 69.04 | 9.78 | 3 | 69846 | 129692 | 110389758 |
| Folliculitis | 67.82 | 9.78 | 12 | 69837 | 167641 | 110351809 |
| Rheumatoid factor positive | 67.05 | 9.78 | 4 | 69845 | 131636 | 110387814 |
| Product use issue | 66.91 | 9.78 | 59 | 69790 | 311636 | 110207814 |
| Myalgia | 66.79 | 9.78 | 298 | 69551 | 222083 | 110297367 |
| Fatigue | 65.83 | 9.78 | 1105 | 68744 | 1214853 | 109304597 |
| Device expulsion | 65.62 | 9.78 | 89 | 69760 | 30802 | 110488648 |
| Plasma cell myeloma | 65.04 | 9.78 | 131 | 69718 | 62805 | 110456645 |
| Maternal exposure during pregnancy | 64.01 | 9.78 | 41 | 69808 | 254842 | 110264608 |
| Flushing | 62.46 | 9.78 | 176 | 69673 | 104560 | 110414890 |
| Intentional product use issue | 62.09 | 9.78 | 40 | 69809 | 247866 | 110271584 |
| Muscle injury | 61.71 | 9.78 | 8 | 69841 | 140799 | 110378651 |
| Cardiac failure congestive | 60.21 | 9.78 | 221 | 69628 | 150779 | 110368671 |
| C-reactive protein increased | 59.03 | 9.78 | 32 | 69817 | 217887 | 110301563 |
| Dehydration | 58.91 | 9.78 | 339 | 69510 | 279172 | 110240278 |
| Rheumatic fever | 58.76 | 9.78 | 5 | 69844 | 122574 | 110396876 |
| Asthenia | 57.78 | 9.78 | 677 | 69172 | 688322 | 109831128 |
| Wound | 55.80 | 9.78 | 40 | 69809 | 234397 | 110285053 |
| Deep vein thrombosis | 55.15 | 9.78 | 204 | 69645 | 139683 | 110379767 |
| Drug ineffective | 54.62 | 9.78 | 657 | 69192 | 1519883 | 108999567 |
| Irritable bowel syndrome | 52.52 | 9.78 | 19 | 69830 | 164196 | 110355254 |
| Therapeutic product effect incomplete | 50.93 | 9.78 | 40 | 69809 | 223765 | 110295685 |
| Haemoglobin decreased | 50.67 | 9.78 | 299 | 69550 | 248428 | 110271022 |
| Feeling abnormal | 50.41 | 9.78 | 237 | 69612 | 180474 | 110338976 |
| Sleep disorder due to general medical condition, insomnia type | 48.80 | 9.78 | 5 | 69844 | 105638 | 110413812 |
| Fibromyalgia | 47.91 | 9.78 | 24 | 69825 | 170885 | 110348565 |
| Full blood count decreased | 46.05 | 9.78 | 77 | 69772 | 32022 | 110487428 |
| Hepatic enzyme increased | 45.68 | 9.78 | 83 | 69766 | 320809 | 110198641 |
| Liver injury | 45.46 | 9.78 | 19 | 69830 | 150394 | 110369056 |
| Myelosuppression | 44.80 | 9.78 | 4 | 69845 | 94336 | 110425114 |
| COVID-19 | 43.99 | 9.78 | 54 | 69795 | 245006 | 110274444 |
| Unevaluable event | 41.85 | 9.78 | 106 | 69743 | 59121 | 110460329 |
| Joint swelling | 41.58 | 9.78 | 142 | 69707 | 442703 | 110076747 |
| Facet joint syndrome | 41.25 | 9.78 | 6 | 69843 | 96822 | 110422628 |
| Ill-defined disorder | 41.08 | 9.78 | 24 | 69825 | 156829 | 110362621 |
| Lip dry | 40.83 | 9.78 | 7 | 69842 | 100076 | 110419374 |
| International normalised ratio increased | 40.65 | 9.78 | 134 | 69715 | 86638 | 110432812 |
| Type 2 diabetes mellitus | 39.92 | 9.78 | 32 | 69817 | 177200 | 110342250 |
| Muscle spasms | 39.60 | 9.78 | 306 | 69543 | 277851 | 110241599 |
| Nausea | 38.08 | 9.78 | 1035 | 68814 | 1234655 | 109284795 |
| Arthropathy | 36.09 | 9.78 | 80 | 69769 | 287442 | 110232008 |
| Mental status changes | 36.06 | 9.78 | 118 | 69731 | 76004 | 110443446 |
| Dyspnoea exertional | 35.50 | 9.78 | 145 | 69704 | 103915 | 110415535 |
| Dyspnoea | 34.90 | 9.78 | 930 | 68919 | 1105942 | 109413508 |
| Urticaria thermal | 34.88 | 9.78 | 13 | 69836 | 518 | 110518932 |
| Back pain | 34.86 | 9.78 | 373 | 69476 | 370623 | 110148827 |
| Hypervolaemia | 34.40 | 9.78 | 88 | 69761 | 49372 | 110470078 |
| Fluid retention | 34.25 | 9.78 | 134 | 69715 | 94173 | 110425277 |
| Myocardial infarction | 34.14 | 9.78 | 223 | 69626 | 191860 | 110327590 |
| Swollen joint count increased | 33.80 | 9.78 | 6 | 69843 | 83655 | 110435795 |
| Administration site erythema | 33.49 | 9.78 | 12 | 69837 | 427 | 110519023 |
| Epilepsy | 33.06 | 9.78 | 11 | 69838 | 100198 | 110419252 |
| Device dislocation | 32.76 | 9.78 | 66 | 69783 | 31638 | 110487812 |
| Impaired healing | 32.58 | 9.78 | 46 | 69803 | 196671 | 110322779 |
| Gastrointestinal haemorrhage | 32.43 | 9.78 | 197 | 69652 | 165321 | 110354129 |
| Condition aggravated | 32.11 | 9.78 | 303 | 69546 | 734533 | 109784917 |
| Blister | 31.30 | 9.78 | 60 | 69789 | 227316 | 110292134 |
| Wheezing | 31.23 | 9.78 | 72 | 69777 | 255158 | 110264292 |
| Discoloured vomit | 30.94 | 9.78 | 18 | 69831 | 1999 | 110517451 |
| Obesity | 30.17 | 9.78 | 17 | 69832 | 113334 | 110406116 |
| Mobility decreased | 29.84 | 9.78 | 66 | 69783 | 237356 | 110282094 |
| Nasal congestion | 29.70 | 9.78 | 132 | 69717 | 98150 | 110421300 |
| Stomatitis | 29.37 | 9.78 | 81 | 69768 | 270161 | 110249289 |
| Cerebrovascular accident | 28.96 | 9.78 | 205 | 69644 | 181079 | 110338371 |
| Flatulence | 28.54 | 9.78 | 85 | 69764 | 52064 | 110467386 |
| Cytokine release syndrome | 28.50 | 9.78 | 5 | 69844 | 70301 | 110449149 |
| Rheumatoid arthritis | 28.15 | 9.78 | 96 | 69753 | 299517 | 110219933 |
| Tremor | 27.95 | 9.78 | 221 | 69628 | 202011 | 110317439 |
| Multiple sclerosis relapse | 27.60 | 9.78 | 82 | 69767 | 50158 | 110469292 |
| Discomfort | 27.55 | 9.78 | 59 | 69790 | 214648 | 110304802 |
| Cardiac disorder | 27.38 | 9.78 | 108 | 69741 | 76172 | 110443278 |
| Blood triglycerides increased | 27.38 | 9.78 | 52 | 69797 | 23874 | 110495576 |
| Intentional overdose | 27.32 | 9.78 | 26 | 69823 | 132475 | 110386975 |
| Pneumonia | 27.11 | 9.78 | 735 | 69114 | 875979 | 109643471 |
| Gastrointestinal disorder | 26.68 | 9.78 | 72 | 69777 | 241880 | 110277570 |
| Hypercholesterolaemia | 26.61 | 9.78 | 12 | 69837 | 90825 | 110428625 |
| Haematocrit decreased | 26.53 | 9.78 | 97 | 69752 | 66020 | 110453430 |
| Peripheral venous disease | 26.44 | 9.78 | 10 | 69839 | 84107 | 110435343 |
| Bursitis | 26.20 | 9.78 | 26 | 69823 | 129892 | 110389558 |
| Chills | 26.19 | 9.78 | 208 | 69641 | 190372 | 110329078 |
| Grip strength decreased | 26.10 | 9.78 | 9 | 69840 | 80165 | 110439285 |
| Hip fracture | 25.97 | 9.78 | 64 | 69785 | 35087 | 110484363 |
| Blood glucose increased | 25.51 | 9.78 | 157 | 69692 | 132339 | 110387111 |
| Alopecia | 25.50 | 9.78 | 131 | 69718 | 364622 | 110154828 |
| Injection site haemorrhage | 25.33 | 9.78 | 61 | 69788 | 32967 | 110486483 |
| Femoral artery dissection | 25.28 | 9.78 | 6 | 69843 | 46 | 110519404 |
| Therapeutic product effect decreased | 25.25 | 9.78 | 75 | 69774 | 244241 | 110275209 |
| Dysgeusia | 25.05 | 9.78 | 99 | 69750 | 69886 | 110449564 |
| Injection site pain | 24.90 | 9.78 | 195 | 69654 | 177727 | 110341723 |
| Influenza like illness | 24.67 | 9.78 | 116 | 69733 | 88296 | 110431154 |
| Internal haemorrhage | 24.46 | 9.78 | 31 | 69818 | 10040 | 110509410 |
| Febrile neutropenia | 24.33 | 9.78 | 110 | 69739 | 316657 | 110202793 |
| Headache | 24.30 | 9.78 | 729 | 69120 | 881648 | 109637802 |
| Pelvic pain | 23.89 | 9.78 | 39 | 69810 | 15903 | 110503547 |
| Coronary artery disease | 23.74 | 9.78 | 99 | 69750 | 71591 | 110447859 |
| Hospice care | 23.60 | 9.78 | 34 | 69815 | 12439 | 110507011 |
| Lung disorder | 23.50 | 9.78 | 49 | 69800 | 179998 | 110339452 |
| Cellulitis | 23.43 | 9.78 | 148 | 69701 | 125868 | 110393582 |
| Bronchitis | 23.03 | 9.78 | 174 | 69675 | 156858 | 110362592 |
| Constipation | 22.95 | 9.78 | 335 | 69514 | 357451 | 110161999 |
| Oedema peripheral | 22.79 | 9.78 | 312 | 69537 | 328348 | 110191102 |
| Joint range of motion decreased | 22.76 | 9.78 | 26 | 69823 | 121806 | 110397644 |
| Urinary tract infection | 22.32 | 9.78 | 309 | 69540 | 325973 | 110193477 |
| Coma | 22.18 | 9.78 | 25 | 69824 | 117844 | 110401606 |
| Injection site bruising | 22.10 | 9.78 | 77 | 69772 | 51186 | 110468264 |
| Small intestinal obstruction | 22.08 | 9.78 | 57 | 69792 | 32156 | 110487294 |
| Nervousness | 22.03 | 9.78 | 62 | 69787 | 36789 | 110482661 |
| Autoimmune disorder | 21.93 | 9.78 | 7 | 69842 | 65476 | 110453974 |
| Agranulocytosis | 21.78 | 9.78 | 6 | 69843 | 61754 | 110457696 |
| Eosinophilia | 21.65 | 9.78 | 5 | 69844 | 57931 | 110461519 |
| Hepatic function abnormal | 21.55 | 9.78 | 15 | 69834 | 89280 | 110430170 |
| Intentional product misuse | 21.10 | 9.78 | 32 | 69817 | 132872 | 110386578 |
| Pulmonary fibrosis | 21.06 | 9.78 | 20 | 69829 | 102022 | 110417428 |
| Wound infection | 20.99 | 9.78 | 18 | 69831 | 96447 | 110423003 |
| Complication associated with device | 20.99 | 9.78 | 42 | 69807 | 20031 | 110499419 |
| Inflammation | 20.93 | 9.78 | 58 | 69791 | 193180 | 110326270 |
| Dizziness postural | 20.89 | 9.78 | 35 | 69814 | 14574 | 110504876 |
| Blood testosterone decreased | 20.77 | 9.78 | 16 | 69833 | 2832 | 110516618 |
| Prescribed overdose | 20.75 | 9.78 | 15 | 69834 | 87566 | 110431884 |
| Interstitial lung disease | 20.75 | 9.78 | 35 | 69814 | 139299 | 110380151 |
| Atrial fibrillation | 20.68 | 9.78 | 229 | 69620 | 229413 | 110290037 |
| Drug interaction | 20.65 | 9.78 | 209 | 69640 | 499974 | 110019476 |
| Chest pain | 20.56 | 9.78 | 343 | 69506 | 376032 | 110143418 |
| Blood potassium decreased | 20.55 | 9.78 | 78 | 69771 | 54036 | 110465414 |
| Drug ineffective for unapproved indication | 20.26 | 9.78 | 21 | 69828 | 102817 | 110416633 |
| Coronary artery occlusion | 20.22 | 9.78 | 36 | 69813 | 15736 | 110503714 |
| Weight decreased | 20.15 | 9.78 | 411 | 69438 | 467646 | 110051804 |
| Blood glucose decreased | 20.02 | 9.78 | 52 | 69797 | 29436 | 110490014 |
| Hypoacusis | 19.87 | 9.78 | 58 | 69791 | 35133 | 110484317 |
| White blood cell count decreased | 19.86 | 9.78 | 227 | 69622 | 229163 | 110290287 |
| Rotator cuff syndrome | 19.84 | 9.78 | 37 | 69812 | 16757 | 110502693 |
| Asthma | 19.77 | 9.78 | 86 | 69763 | 250205 | 110269245 |
| Injection site erythema | 19.66 | 9.78 | 114 | 69735 | 94062 | 110425388 |
| Aspartate aminotransferase increased | 19.54 | 9.78 | 170 | 69679 | 159766 | 110359684 |
| Influenza | 19.25 | 9.78 | 177 | 69672 | 168924 | 110350526 |
| Thrombosis | 19.20 | 9.78 | 126 | 69723 | 108536 | 110410914 |
| Eye swelling | 19.17 | 9.78 | 55 | 69794 | 32993 | 110486457 |
| Live birth | 19.11 | 9.78 | 10 | 69839 | 69474 | 110449976 |
| Neuropathy peripheral | 19.09 | 9.78 | 185 | 69664 | 179092 | 110340358 |
| Drug resistance | 18.93 | 9.78 | 6 | 69843 | 56368 | 110463082 |
| Viral infection | 18.88 | 9.78 | 75 | 69774 | 53064 | 110466386 |
| Overdose | 18.67 | 9.78 | 80 | 69769 | 233714 | 110285736 |
| Low density lipoprotein increased | 18.63 | 9.78 | 28 | 69821 | 10638 | 110508812 |
| Pulmonary embolism | 18.46 | 9.78 | 212 | 69637 | 214262 | 110305188 |
| Atelectasis | 18.37 | 9.78 | 58 | 69791 | 36654 | 110482796 |
| Exposure during pregnancy | 18.32 | 9.78 | 50 | 69799 | 167374 | 110352076 |
| Product complaint | 18.05 | 9.78 | 32 | 69817 | 13940 | 110505510 |
| Nail disorder | 18.02 | 9.78 | 7 | 69842 | 57928 | 110461522 |
| Dislocation of vertebra | 17.96 | 9.78 | 3 | 69846 | 43718 | 110475732 |
| Sleep disorder | 17.75 | 9.78 | 65 | 69784 | 198579 | 110320871 |
| Hepatocellular injury | 17.71 | 9.78 | 5 | 69844 | 50637 | 110468813 |
| Coeliac disease | 17.66 | 9.78 | 3 | 69846 | 43184 | 110476266 |
| Pleural effusion | 17.29 | 9.78 | 180 | 69669 | 177529 | 110341921 |
| Meningitis cryptococcal | 17.22 | 9.78 | 18 | 69831 | 4744 | 110514706 |
| Platelet count decreased | 16.89 | 9.78 | 221 | 69628 | 230222 | 110289228 |
| Cholestasis | 16.71 | 9.78 | 10 | 69839 | 64508 | 110454942 |
| Occult blood positive | 16.65 | 9.78 | 22 | 69827 | 7423 | 110512027 |
| Hypersensitivity | 16.59 | 9.78 | 169 | 69680 | 403829 | 110115621 |
| Red blood cell sedimentation rate increased | 16.57 | 9.78 | 15 | 69834 | 78287 | 110441163 |
| Blepharospasm | 16.46 | 9.78 | 7 | 69842 | 54844 | 110464606 |
| Infection | 16.36 | 9.78 | 148 | 69701 | 362052 | 110157398 |
| Pain in extremity | 16.35 | 9.78 | 413 | 69436 | 486705 | 110032745 |
| Acute respiratory failure | 16.30 | 9.78 | 92 | 69757 | 75168 | 110444282 |
| Altered state of consciousness | 16.28 | 9.78 | 8 | 69841 | 57618 | 110461832 |
| Lethargy | 16.23 | 9.78 | 108 | 69741 | 93468 | 110425982 |
| Gait disturbance | 16.10 | 9.78 | 256 | 69593 | 277952 | 110241498 |
| Swelling | 16.05 | 9.78 | 143 | 69706 | 350898 | 110168552 |
| Muscle fatigue | 16.04 | 9.78 | 16 | 69833 | 3991 | 110515459 |
| Pulmonary arterial hypertension | 15.88 | 9.78 | 51 | 69798 | 32517 | 110486933 |
| Pulmonary hypertension | 15.81 | 9.78 | 73 | 69776 | 55147 | 110464303 |
| Pain in jaw | 15.66 | 9.78 | 69 | 69780 | 51108 | 110468342 |
| Bone erosion | 15.45 | 9.78 | 5 | 69844 | 46366 | 110473084 |
| Hypertension | 15.41 | 9.78 | 228 | 69621 | 509856 | 110009594 |
| Depression | 15.11 | 9.78 | 283 | 69566 | 317052 | 110202398 |
| Neurotoxicity | 15.08 | 9.78 | 4 | 69845 | 42203 | 110477247 |
| Transient ischaemic attack | 15.06 | 9.78 | 80 | 69769 | 63902 | 110455548 |
| Haemodialysis | 14.98 | 9.78 | 34 | 69815 | 17685 | 110501765 |
| Hypoxia | 14.96 | 9.78 | 136 | 69713 | 129379 | 110390071 |
| Drug reaction with eosinophilia and systemic symptoms | 14.82 | 9.78 | 18 | 69831 | 82077 | 110437373 |
| Anaphylactic shock | 14.80 | 9.78 | 7 | 69842 | 51539 | 110467911 |
| Sinoatrial block | 14.73 | 9.78 | 10 | 69839 | 1455 | 110517995 |
| Cytomegalovirus infection | 14.73 | 9.78 | 8 | 69841 | 54436 | 110465014 |
| Body height decreased | 14.70 | 9.78 | 25 | 69824 | 10538 | 110508912 |
| Psoriatic arthropathy | 14.70 | 9.78 | 69 | 69780 | 196692 | 110322758 |
| Psoriasis | 14.67 | 9.78 | 144 | 69705 | 139849 | 110379601 |
| Multiple organ dysfunction syndrome | 14.66 | 9.78 | 48 | 69801 | 151662 | 110367788 |
| Liver disorder | 14.45 | 9.78 | 44 | 69805 | 142199 | 110377251 |
| Leukopenia | 14.43 | 9.78 | 47 | 69802 | 148744 | 110370706 |
| Transfusion | 14.40 | 9.78 | 42 | 69807 | 25430 | 110494020 |
| Blood potassium increased | 14.38 | 9.78 | 50 | 69799 | 33199 | 110486251 |
| Myopathy | 13.96 | 9.78 | 41 | 69808 | 24919 | 110494531 |
| Skin laceration | 13.95 | 9.78 | 50 | 69799 | 33703 | 110485747 |
| Hypophagia | 13.92 | 9.78 | 68 | 69781 | 52558 | 110466892 |
| Vaginal haemorrhage | 13.84 | 9.78 | 41 | 69808 | 25033 | 110494417 |
| Hot flush | 13.82 | 9.78 | 80 | 69769 | 65956 | 110453494 |
| Mitral valve repair | 13.80 | 9.78 | 6 | 69843 | 358 | 110519092 |
| Failure to thrive | 13.72 | 9.78 | 28 | 69821 | 13546 | 110505904 |
| Sleep disorder due to a general medical condition | 13.60 | 9.78 | 8 | 69841 | 52104 | 110467346 |
| Eustachian tube obstruction | 13.25 | 9.78 | 4 | 69845 | 82 | 110519368 |
| Vision blurred | 13.17 | 9.78 | 132 | 69717 | 128890 | 110390560 |
| Bone pain | 13.05 | 9.78 | 78 | 69771 | 65055 | 110454395 |
| Transaminases abnormal | 13.03 | 9.78 | 8 | 69841 | 980 | 110518470 |
| Neoplasm progression | 12.94 | 9.78 | 13 | 69836 | 64582 | 110454868 |
| Rash pruritic | 12.90 | 9.78 | 106 | 69743 | 97963 | 110421487 |
| Depressed level of consciousness | 12.68 | 9.78 | 33 | 69816 | 112245 | 110407205 |
| Pericardial haemorrhage | 12.58 | 9.78 | 16 | 69833 | 5201 | 110514249 |
| Radioisotope scan abnormal | 12.44 | 9.78 | 7 | 69842 | 730 | 110518720 |
| Laryngeal pain | 12.36 | 9.78 | 17 | 69832 | 5958 | 110513492 |
| Post procedural haemorrhage | 12.27 | 9.78 | 29 | 69820 | 15483 | 110503967 |
| Rib fracture | 12.27 | 9.78 | 48 | 69801 | 33722 | 110485728 |
| Sinus headache | 12.24 | 9.78 | 17 | 69832 | 6015 | 110513435 |
| Therapeutic response unexpected | 12.24 | 9.78 | 38 | 69811 | 23805 | 110495645 |
| Scratch | 12.21 | 9.78 | 26 | 69823 | 12953 | 110506497 |
| Hepatitis | 12.18 | 9.78 | 24 | 69825 | 90030 | 110429420 |
| Obstructive airways disorder | 12.17 | 9.78 | 7 | 69842 | 46142 | 110473308 |
| Chronic kidney disease | 12.01 | 9.78 | 86 | 69763 | 76205 | 110443245 |
| Red blood cell count decreased | 11.99 | 9.78 | 77 | 69772 | 65846 | 110453604 |
| Suicide attempt | 11.98 | 9.78 | 30 | 69819 | 103364 | 110416086 |
| Toxic epidermal necrolysis | 11.84 | 9.78 | 11 | 69838 | 56716 | 110462734 |
| Ageusia | 11.69 | 9.78 | 33 | 69816 | 19612 | 110499838 |
| Retinitis | 11.67 | 9.78 | 3 | 69846 | 32324 | 110487126 |
| Application site erythema | 11.67 | 9.78 | 16 | 69833 | 5594 | 110513856 |
| Ventricular hypertrophy | 11.61 | 9.78 | 18 | 69831 | 7027 | 110512423 |
| Onychomycosis | 11.43 | 9.78 | 5 | 69844 | 38526 | 110480924 |
| Sciatica | 11.35 | 9.78 | 26 | 69823 | 92373 | 110427077 |
| Balance disorder | 11.30 | 9.78 | 118 | 69731 | 116442 | 110403008 |
| Heavy menstrual bleeding | 11.26 | 9.78 | 29 | 69820 | 16336 | 110503114 |
| Gallbladder disorder | 11.24 | 9.78 | 34 | 69815 | 20995 | 110498455 |
| X-ray abnormal | 11.22 | 9.78 | 5 | 69844 | 38112 | 110481338 |
| Syncope | 11.20 | 9.78 | 185 | 69664 | 202351 | 110317099 |
| Infective pulmonary exacerbation of cystic fibrosis | 11.02 | 9.78 | 27 | 69822 | 14744 | 110504706 |
| Wound drainage | 11.01 | 9.78 | 8 | 69841 | 1296 | 110518154 |
| Drug-induced liver injury | 10.91 | 9.78 | 39 | 69810 | 120028 | 110399422 |
| Delirium | 10.90 | 9.78 | 46 | 69803 | 134979 | 110384471 |
| Sedation | 10.85 | 9.78 | 17 | 69832 | 69666 | 110449784 |
| Injection site nodule | 10.81 | 9.78 | 14 | 69835 | 4632 | 110514818 |
| Very low density lipoprotein increased | 10.79 | 9.78 | 5 | 69844 | 347 | 110519103 |
| Lactic acidosis | 10.70 | 9.78 | 27 | 69822 | 92784 | 110426666 |
| Drug withdrawal syndrome | 10.67 | 9.78 | 50 | 69799 | 38004 | 110481446 |
| Multiple sclerosis | 10.56 | 9.78 | 38 | 69811 | 25660 | 110493790 |
| Application site pain | 10.42 | 9.78 | 15 | 69834 | 5484 | 110513966 |
| Tricuspid valve incompetence | 10.41 | 9.78 | 36 | 69813 | 23837 | 110495613 |
| Renal impairment | 10.35 | 9.78 | 73 | 69776 | 188372 | 110331078 |
| Left atrial dilatation | 10.35 | 9.78 | 12 | 69837 | 3548 | 110515902 |
| Abdominal pain | 10.34 | 9.78 | 409 | 69440 | 512580 | 110006870 |
| Diabetic retinopathy | 10.33 | 9.78 | 12 | 69837 | 3552 | 110515898 |
| Granulocytopenia | 10.31 | 9.78 | 24 | 69825 | 12691 | 110506759 |
| Musculoskeletal stiffness | 10.30 | 9.78 | 120 | 69729 | 279702 | 110239748 |
| Meniscus injury | 10.26 | 9.78 | 18 | 69831 | 7775 | 110511675 |
| Cardiac pacemaker insertion | 10.24 | 9.78 | 16 | 69833 | 6285 | 110513165 |
| Metabolic encephalopathy | 10.23 | 9.78 | 22 | 69827 | 11038 | 110508412 |
| Application site discolouration | 10.17 | 9.78 | 7 | 69842 | 1042 | 110518408 |
| Cyst | 10.10 | 9.78 | 28 | 69821 | 16468 | 110502982 |
| High density lipoprotein decreased | 9.94 | 9.78 | 15 | 69834 | 5718 | 110513732 |
| Pulse absent | 9.92 | 9.78 | 22 | 69827 | 11270 | 110508180 |
| Rash maculo-papular | 9.85 | 9.78 | 20 | 69829 | 74202 | 110445248 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | C04AC01 | CARDIOVASCULAR SYSTEM PERIPHERAL VASODILATORS PERIPHERAL VASODILATORS Nicotinic acid and derivatives |
| ATC | C10AD02 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, PLAIN Nicotinic acid and derivatives |
| ATC | C10AD52 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, PLAIN Nicotinic acid and derivatives |
| ATC | C10BA01 | CARDIOVASCULAR SYSTEM LIPID MODIFYING AGENTS LIPID MODIFYING AGENTS, COMBINATIONS Combinations of various lipid modifying agents |
| FDA CS | M0014839 | Nicotinic Acids |
| MeSH PA | D000960 | Hypolipidemic Agents |
| MeSH PA | D000963 | Antimetabolites |
| MeSH PA | D002317 | Cardiovascular Agents |
| MeSH PA | D014665 | Vasodilator Agents |
| MeSH PA | D014803 | Vitamin B Complex |
| MeSH PA | D014815 | Vitamins |
| MeSH PA | D018977 | Micronutrients |
| MeSH PA | D057847 | Lipid Regulating Agents |
| FDA EPC | N0000175594 | Nicotinic Acid |
| CHEBI has role | CHEBI:35610 | antineoplastic agent |
| CHEBI has role | CHEBI:25212 | metabolite |
| CHEBI has role | CHEBI:33231 | antitubercular agent |
| CHEBI has role | CHEBI:35469 | antidepressant |
| CHEBI has role | CHEBI:35474 | anxiolytic drug |
| CHEBI has role | CHEBI:35476 | antipsychotic agent |
| CHEBI has role | CHEBI:35480 | analgesic |
| CHEBI has role | CHEBI:35526 | hypoglycemic agent |
| CHEBI has role | CHEBI:35554 | cardiovascular drug |
| CHEBI has role | CHEBI:35620 | vasodilator agent |
| CHEBI has role | CHEBI:35679 | antilipemic drug |
| CHEBI has role | CHEBI:35821 | anticholesteremic drug |
| CHEBI has role | CHEBI:50247 | antidote |
| CHEBI has role | CHEBI:64946 | anti-HIV agent |
| CHEBI has role | CHEBI:74518 | anti-obesity agent |
| CHEBI has role | CHEBI:75771 | mouse metabolite |
| CHEBI has role | CHEBI:75835 | anti-anaemic agent |
| CHEBI has role | CHEBI:76924 | plant metabolite |
| CHEBI has role | CHEBI:76971 | <em>Escherichia coli</em> metabolite |
| CHEBI has role | CHEBI:84087 | human urinary metabolite |
| CHEBI has role | CHEBI:84264 | EC 3.5.1.19 (nicotinamidase) inhibitor |
| CHEBI has role | CHEBI:145947 | antiatherosclerotic agent |
| CHEBI has role | CHEBI:231911 | renoprotective agent |
Related Drugs by ATC class:
C04AC Nicotinic acid and derivatives 3 drugs
C10AD Nicotinic acid and derivatives 5 drugs
C10BA Combinations of various lipid modifying agents 9 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Hypercholesterolemia | indication | 13644009 | |
| Hyperlipidemia | indication | 55822004 | DOID:1168 |
| Vitamin deficiency | indication | 85670002 | |
| Familial hypercholesterolemia - heterozygous | indication | 238079002 | |
| Mixed hyperlipidemia | indication | 267434003 | |
| Hypertriglyceridemia | indication | 302870006 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 2.31 | acidic |
| pKa2 | 4.85 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Hydroxycarboxylic acid receptor 2 | GPCR | AGONIST | Ki | 7.30 | CHEMBL | SCIENTIFIC LITERATURE | |||
| Nicotinamide N-methyltransferase | Enzyme | WOMBAT-PK | |||||||
| Nicotinate-nucleotide pyrophosphorylase [carboxylating] | Enzyme | WOMBAT-PK | |||||||
| Nicotinamide phosphoribosyltransferase | Enzyme | WOMBAT-PK | |||||||
| Hydroxycarboxylic acid receptor 3 | GPCR | AGONIST | EC50 | 6.52 | IUPHAR | ||||
| Amyloid beta A4 protein | Membrane other | IC50 | 4.88 | CHEMBL | |||||
| Hydroxycarboxylic acid receptor 2 | GPCR | IC50 | 6.85 | CHEMBL | |||||
| Hydroxycarboxylic acid receptor 2 | GPCR | Ki | 7.48 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| 4019440 | VUID |
| N0000147570 | NUI |
| D00049 | KEGG_DRUG |
| 4017632 | VANDF |
| 4017661 | VANDF |
| 4017718 | VANDF |
| 4019440 | VANDF |
| 4020285 | VANDF |
| 4021898 | VANDF |
| C0027996 | UMLSCUI |
| CHEBI:15940 | CHEBI |
| NIO | PDB_CHEM_ID |
| CHEMBL573 | ChEMBL_ID |
| 938 | PUBCHEM_CID |
| DB00627 | DRUGBANK_ID |
| 1588 | IUPHAR_LIGAND_ID |
| 218728 | RXNORM |
| 2275 | MMSL |
| 43641 | MMSL |
| 4947 | MMSL |
| 5169 | MMSL |
| 5170 | MMSL |
| 5684 | MMSL |
| 59920 | MMSL |
| 7159 | MMSL |
| 7161 | MMSL |
| 72420 | MMSL |
| d00314 | MMSL |
| d03739 | MMSL |
| 001052 | NDDF |
| 001055 | NDDF |
| 173196005 | SNOMEDCT_US |
| 273943001 | SNOMEDCT_US |
| 63639004 | SNOMEDCT_US |
| D009525 | MESH_DESCRIPTOR_UI |
| 373 | INN_ID |
| 2679MF687A | UNII |
| 2679MF687A | INXIGHT DRUGS |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0378-3901 | TABLET, FILM COATED, EXTENDED RELEASE | 500 mg | ORAL | ANDA | 28 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0378-3902 | TABLET, FILM COATED, EXTENDED RELEASE | 750 mg | ORAL | ANDA | 28 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0378-3903 | TABLET, FILM COATED, EXTENDED RELEASE | 1000 mg | ORAL | ANDA | 28 sections |
| VitafolOne | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0642-0070 | CAPSULE, GELATIN COATED | 15 mg | ORAL | unapproved drug other | 14 sections |
| Select OB | HUMAN PRESCRIPTION DRUG LABEL | 15 | 0642-0077 | TABLET, CHEWABLE | 15 mg | ORAL | UNAPPROVED DRUG OTHER | 14 sections |
| Vitafol OBCaplet | HUMAN PRESCRIPTION DRUG LABEL | 15 | 0642-0079 | TABLET | 18 mg | ORAL | unapproved drug other | 14 sections |
| Vitafol Plus | HUMAN PRESCRIPTION DRUG LABEL | 17 | 0642-0092 | CAPSULE, LIQUID FILLED | 15 mg | ORAL | UNAPPROVED DRUG OTHER | 13 sections |
| Reaphirm Plant Source DHA | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0642-3010 | CAPSULE, GELATIN COATED | 15 mg | ORAL | unapproved drug other | 7 sections |
| O-Cal Prenatal Vitamin | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0813-0202 | TABLET | 17 mg | ORAL | UNAPPROVED DRUG OTHER | 6 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10135-612 | TABLET, EXTENDED RELEASE | 500 mg | ORAL | ANDA | 25 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10135-613 | TABLET, EXTENDED RELEASE | 750 mg | ORAL | ANDA | 25 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10135-614 | TABLET, EXTENDED RELEASE | 1000 mg | ORAL | ANDA | 25 sections |
| JBA Collagen-Electrolyte Mocktail | HUMAN OTC DRUG LABEL | 12 | 13411-848 | POWDER | 18 mg | ORAL | unapproved drug other | 6 sections |
| TriStart DHA | HUMAN PRESCRIPTION DRUG LABEL | 15 | 15370-250 | CAPSULE, LIQUID FILLED | 5 mg | ORAL | UNAPPROVED DRUG OTHER | 12 sections |
| Niaspan | HUMAN PRESCRIPTION DRUG LABEL | 1 | 21695-852 | TABLET, FILM COATED, EXTENDED RELEASE | 500 mg | ORAL | NDA | 26 sections |
| Niaspan | HUMAN PRESCRIPTION DRUG LABEL | 1 | 21695-865 | TABLET, FILM COATED, EXTENDED RELEASE | 1000 mg | ORAL | NDA | 26 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 33342-187 | TABLET | 500 mg | ORAL | ANDA | 25 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 33342-189 | TABLET | 1000 mg | ORAL | ANDA | 25 sections |
| NIACIN | Human Prescription Drug Label | 1 | 47335-539 | TABLET, FILM COATED, EXTENDED RELEASE | 500 mg | ORAL | ANDA | 27 sections |
| NIACIN | Human Prescription Drug Label | 1 | 47335-613 | TABLET, FILM COATED, EXTENDED RELEASE | 1000 mg | ORAL | ANDA | 27 sections |
| NIACIN | Human Prescription Drug Label | 1 | 47335-614 | TABLET, FILM COATED, EXTENDED RELEASE | 750 mg | ORAL | ANDA | 27 sections |
| Multivitamin with fluoride | HUMAN PRESCRIPTION DRUG LABEL | 11 | 50090-0356 | TABLET, CHEWABLE | 13.50 mg | ORAL | UNAPPROVED DRUG OTHER | 8 sections |
| Multivitamin with fluoride | HUMAN PRESCRIPTION DRUG LABEL | 11 | 50090-0435 | TABLET, CHEWABLE | 13.50 mg | ORAL | UNAPPROVED DRUG OTHER | 8 sections |
| Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 12 | 50090-4475 | TABLET, CHEWABLE | 13.50 mg | ORAL | unapproved drug other | 10 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50268-584 | TABLET, EXTENDED RELEASE | 500 mg | ORAL | ANDA | 19 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50268-584 | TABLET, EXTENDED RELEASE | 500 mg | ORAL | ANDA | 19 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50268-586 | TABLET, EXTENDED RELEASE | 1000 mg | ORAL | ANDA | 19 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50268-586 | TABLET, EXTENDED RELEASE | 1000 mg | ORAL | ANDA | 19 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-267 | TABLET, EXTENDED RELEASE | 500 mg | ORAL | ANDA | 25 sections |
| Niacin | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-268 | TABLET, EXTENDED RELEASE | 1000 mg | ORAL | ANDA | 25 sections |